CCMI Announces Second Tranche Closing of LIFE Offering
aTyr PharmaaTyr Pharma(US:LIFE) TMX Newsfile·2025-12-30 11:00

Core Viewpoint - Canadian Critical Minerals Inc. has successfully closed the second and final tranche of its private placement, raising a total of $162,785 through the issuance of 4,650,999 units, bringing the total gross proceeds from both tranches to $751,635 [1][2]. Group 1: Offering Details - Each unit consists of one common share and one common share purchase warrant, with the warrant exercisable into one common share at a price of $0.05 for five years [2]. - The offering is subject to final approval from the TSX Venture Exchange [2]. - The units were issued under the listed issuer financing exemption, allowing Canadian purchasers to trade the common shares and warrants freely under applicable Canadian securities laws [3]. Group 2: Financial Aspects - The company paid finders fees of $2,305 and issued 65,870 finders warrants, each allowing the purchase of one common share at $0.05 for two years [5]. - The proceeds from the offering will be used to restart the Bull River Mine project and for working capital [6]. Group 3: Company Overview - Canadian Critical Minerals Inc. focuses on copper production assets in Canada, with its main asset being the Bull River Mine project, which contains 150 million lbs of copper [8]. - The company also holds a 5.3% interest in XXIX Metal Corp., which owns the Thierry copper project and the Opemiska copper project [8].

aTyr Pharma-CCMI Announces Second Tranche Closing of LIFE Offering - Reportify